About Plato BioPharma
Plato BioPharma is a Healthcare company based in Westminster (United States) founded in 2010, and was acquired by Inotiv in October 2021. Provider of in vivo studies and also offering biochemical, biomarker, and histology services. Plato BioPharma has raised $600 thousand across 2 funding rounds from investors including Inotiv Co. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include BioQual and Headlands Research.
Company details
Plato BioPharma was founded in 2010 and is based in Westminster, United States. Operations focus on preclinical testing services within the biopharmaceutical sector, including in vitro and in vivo evaluations across cardiovascular, renal, pulmonary, diabetes, and hepatic areas. Capabilities encompass physiological assessments of disease models, chronic response evaluations, histologic analyses, and biomarker measurements. Additional services cover small animal surgeries, compound administrations, necropsy procedures, immunoassays, and ex vivo tension recordings.
- Headquarters Westminster, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website platobiopharma.com
- Social LinkedIn
- Acquired by Inotiv (Oct 2021)
Funding Insights of Plato BioPharma
Plato BioPharma has successfully raised a total of $600K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $600 thousand completed in May 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $600,000
- Total Rounds 2
- Last Round Seed — $600,000
All 2 funding rounds of Plato BioPharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2010 | Debt – Conventional | – | – | – | |
| May 2010 | $600,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Plato BioPharma
Plato BioPharma has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical development and regulatory services are provided by Inotiv. | 1974 | inotivco.com | Lafayette, United States |
Investor details for Plato BioPharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Plato BioPharma
138 people are tracked at Plato BioPharma (70 in leadership, 6 in board & advisors, 62 in team).
| Name | Role | Group |
|---|---|---|
Johnathan Furr | Director Developmental And Reproductive Toxicology | Leadership |
Robert Leasure Jr. | CEO | Leadership |
Beth A. Taylor | SVP, Finance & CFO | Leadership |
Lizanne Muller | Group President, RMS | Leadership |
Mike Garrett | Chief Commercial Officer | Leadership |
Jaymie Voorhees | Study Director II | Leadership |
Chris Null | Study Director | Leadership |
Glenn Washer | Group President, Safety Assessment | Leadership |
Greg Beattie | COO, DSA | Leadership |
John Sagartz | Chief Strategy Officer | Leadership |
Brennan Freeman | Vice President - Finance & Corporate Controller | Leadership |
James Norman | Vice President Of Business Development - Discovery & Translational Sciences | Leadership |
Diane Brecha | Senior Director Business Development | Leadership |
Bryan Lee | US Government Sales Director | Leadership |
Jason Werner | Director, Quality Management Systems | Leadership |
Travis Rothrock | Director, Portfolio Marketing | Leadership |
Cole Mietzner | Vice President - Information Security And Infrastructure | Leadership |
Seth H. | Associate Director Business Development | Leadership |
Nicole McDaniel | Director, Corporate Accounting & External Reporting | Leadership |
Chris Coffman | Senior Director Financial Planning Analysis | Leadership |
118 more people are available in the full profile.
Complete people profiles for Plato BioPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Plato BioPharma
3 dated milestones of Plato BioPharma across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Plato BioPharma is founded.
- Funding First funding round.
- Exit Acquired by Inotiv.
Competitors of Plato BioPharma
Plato BioPharma has 2 listed competitors in our database. They include BioQual and Headlands Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioqual.com | 1981 | Rockville, United States | 193 | Contract research on infectious disease models is conducted. | ||
| headlandsresearch.com | 2018 | San Francisco, United States | Clinical research services are provided by Headlands Research globally. |
Detailed competitors of Plato BioPharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Plato BioPharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Plato Biopharma
Complete news archive for Plato BioPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Plato BioPharma
Plato BioPharma was founded in 2010.
Plato BioPharma is headquartered in Westminster, United States.
Plato BioPharma is a funded company, having raised a total of $600K across 2 funding rounds to date.
Plato BioPharma was founded in 2010 and is based in Westminster, United States. Operations focus on preclinical testing services within the biopharmaceutical sector, including in vitro and in vivo evaluations across cardiovascular, renal, pulmonary, diabetes, and hepatic areas. Capabilities encompass physiological assessments of disease models, chronic response evaluations, histologic analyses, and biomarker measurements. Additional services cover small animal surgeries, compound administrations, necropsy procedures, immunoassays, and ex vivo tension recordings.
Plato BioPharma's top competitors include BioQual and Headlands Research.
Plato BioPharma has 1 investor. Key investors include Inotiv Co.
Yes. Plato BioPharma was acquired by Inotiv in October 2021.